NIB HOLDINGS LIMITED (NHF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NHF - NIB HOLDINGS LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

nib Holdings is an Australian healthcare fund. Originally established in 1952 to provide health insurance to BHP steel workers, it became a listed company in 2007.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.00

23 Mar
2023

0.030

OPEN

$6.93

0.43%

HIGH

$7.01

1,295,305

LOW

$6.92

TARGET
$7.514 7.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
IAG . ISU . MPL . QBE . SDF . SUN . TWR . CVW . GDG . PSI . FCL . NOL . AUB .
FNARENA'S MARKET CONSENSUS FORECASTS
NHF: 1
Title FY21
Actual
FY22
Actual
FY23
Forecast
FY24
Forecast
EPS (cps) xxx 29.6 41.2 xxx
DPS (cps) xxx 22.0 27.0 xxx
EPS Growth xxx - 16.0% 39.1% xxx
DPS Growth xxx - 8.3% 22.7% xxx
PE Ratio xxx N/A 16.9 xxx
Dividend Yield xxx N/A 3.9% xxx
Div Pay Ratio(%) xxx 74.3% 65.6% xxx

Dividend yield today if purchased 3 years ago: 4.37%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.17

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 02/03 - ex-div 13c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title 201720182019202020212022
EPS Basic xxxxxxxxxxxxxxx29.6
DPS All xxxxxxxxxxxxxxx22.0
Sales/Revenue xxxxxxxxxxxxxxx2,793.7 M
Book Value Per Share xxxxxxxxxxxxxxx157.1
Net Operating Cash Flow xxxxxxxxxxxxxxx337.6 M
Net Profit Margin xxxxxxxxxxxxxxx4.86 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201720182019202020212022
Return on Capital Employed xxxxxxxxxxxxxxx19.25 %
Return on Invested Capital xxxxxxxxxxxxxxx13.61 %
Return on Assets xxxxxxxxxxxxxxx7.34 %
Return on Equity xxxxxxxxxxxxxxx19.25 %
Return on Total Capital xxxxxxxxxxxxxxx19.86 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx221.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201720182019202020212022
Short-Term Debt xxxxxxxxxxxxxxx9 M
Long Term Debt xxxxxxxxxxxxxxx303 M
Total Debt xxxxxxxxxxxxxxx312 M
Goodwill - Gross xxxxxxxxxxxxxxx236 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx207 M
Price To Book Value xxxxxxxxxxxxxxx4.70

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201720182019202020212022
Capex xxxxxxxxxxxxxxx26.6 M
Capex % of Sales xxxxxxxxxxxxxxx0.95 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx506 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx1,018 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxxxxxx xx xxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

21/02/2023

1

Upgrade to Buy from Neutral

$8.00

14.29%

First half results were below consensus expectations yet UBS considers these were optimistic. The broker assesses the decline in the nib Holdings stock price is overdone and there is now a unique entry point.

As a result, the rating is upgraded to Buy from Neutral and the target raised to $8.00 from $7.80.

The broker observes policy growth in Australian resident insurance remains buoyant and the brand continues to gain market share. Policy growth is expected to exceed the 3-4% guidance range in FY23.

FORECAST
UBS forecasts a full year FY23 dividend of 27.00 cents and EPS of 41.00 cents.
UBS forecasts a full year FY24 dividend of 27.00 cents and EPS of 42.00 cents.

Credit Suisse

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxxxxx xx xxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

NHF STOCK CHART